AMPHOTERICINE B LIPOSOMAL MEDIPHA 50 mg, powder for dispersion for dilution for dispersion for infusion 10 bottles of 20 ml
Active ingredients: AMPHOTÉRICINE B, AMPHOTÉRICINE B LIPOSOMALE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for dispersion for dilution for infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMPHOTERICINE B LIPOSOMAL MEDIPHA 50 mg, poudre pour dispersion à diluer pour dispersion pour perfusion
- Pharmaceutical form
- poudre pour dispersion à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacons en verre de 20 ml avec filtres
- Marketing authorisation holder
- MEDIPHA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68138844CIP75511071CIP133400955110712Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMPHOTÉRICINE Bpoudre | 50 mg · un flacon | FT |
| AMPHOTÉRICINE B LIPOSOMALEpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.